EP4719329A1 - Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et d'une huile - Google Patents

Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et d'une huile

Info

Publication number
EP4719329A1
EP4719329A1 EP24731496.6A EP24731496A EP4719329A1 EP 4719329 A1 EP4719329 A1 EP 4719329A1 EP 24731496 A EP24731496 A EP 24731496A EP 4719329 A1 EP4719329 A1 EP 4719329A1
Authority
EP
European Patent Office
Prior art keywords
oil
composition according
oils
composition
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24731496.6A
Other languages
German (de)
English (en)
Inventor
Sylvie JALENQUES
Magali MOREAU
Eric DUPONCHEL
Cécilia CLAMENS
Géraldine Lerebour
Julia PUECH
Toni Moine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP4719329A1 publication Critical patent/EP4719329A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition, notamment cosmétique, comprenant, dans un milieu physiologiquement acceptable, au moins une endolysine dérivée d'un phage de Staphylococcus aureus, et au moins une huile autre qu'une paraffine liquide, l'utilisation d'une telle composition pour prévenir et/ou traiter un trouble cutané lié à une colonisation par Staphylococcus aureus chez un individu en ayant besoin, et en particulier pour prévenir et/ou traiter l'acné et/ou l'eczéma chez un individu, et un procédé cosmétique non thérapeutique pour le soin des matières kératiniques, en particulier de la peau, comprenant au moins une étape d'application topique sur lesdites matières kératiniques d'une telle composition.
EP24731496.6A 2023-06-02 2024-05-31 Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et d'une huile Pending EP4719329A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2305549A FR3149202B1 (fr) 2023-06-02 2023-06-02 Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et une huile.
PCT/EP2024/065065 WO2024246305A1 (fr) 2023-06-02 2024-05-31 Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et d'une huile

Publications (1)

Publication Number Publication Date
EP4719329A1 true EP4719329A1 (fr) 2026-04-08

Family

ID=88585413

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24731496.6A Pending EP4719329A1 (fr) 2023-06-02 2024-05-31 Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et d'une huile

Country Status (4)

Country Link
EP (1) EP4719329A1 (fr)
CN (1) CN121941486A (fr)
FR (1) FR3149202B1 (fr)
WO (1) WO2024246305A1 (fr)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668080B1 (fr) 1990-10-17 1993-08-13 Seppic Sa Compositions auto-emulsionnables a base d'alcools gras, leur procede de preparation et leur utilisation pour la realisation d'emulsions.
FR2712595B1 (fr) 1993-11-19 1995-12-22 Seppic Sa Un concentré comportant des alkylglycosides et ses utilisations.
FR2756176B1 (fr) 1996-11-26 1998-12-18 Oreal Composition cosmetique comprenant un compose fluore et presentant un confort ameliore
FR2762317B1 (fr) 1997-04-21 1999-07-09 Seppic Sa Composition a base d'alkylpolyglycosides et d'alcools gras, et ses utilisations
AU2002367820B2 (en) 2001-12-21 2007-11-01 Biosynexus Incorporated Truncated lysostaphin molecule with enhanced staphylolytic activity
WO2008155059A2 (fr) 2007-06-19 2008-12-24 Cognis Ip Management Gmbh Mélanges d'hydrocarbures et leur utilisation
CA2736062A1 (fr) 2008-07-24 2010-01-28 The United State Of America, As Represented By The Secretary Of Agricuure Antimicrobiens triple action refractaires au developpement de resistances
KR101701890B1 (ko) 2009-06-26 2017-02-02 뤼산도 아게 항균제
DK2445515T3 (en) 2009-06-26 2016-07-04 Univ Leuven Kath antimicrobial agents
SG178440A1 (en) 2009-08-24 2012-04-27 Univ Leuven Kath New endolysin obpgplys
PT104837A (pt) 2009-11-24 2011-05-24 Technophage Investiga O E Desenvolvimento Em Biotecnologia S A P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o
EP2338916A1 (fr) 2009-12-23 2011-06-29 Hyglos Invest GmbH Polypeptides chimériques et leur utilisation dans la décolonisation bactérienne
EA037276B1 (ru) 2010-04-27 2021-03-03 Лисандо Аг Способы устранения или уменьшения бактериальной биопленки
GB201018518D0 (en) 2010-11-03 2010-12-15 Univ Leuven Kath Novel endolysin
EP2468856A1 (fr) 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Agents antimicrobiens
WO2012094004A1 (fr) 2011-01-05 2012-07-12 The United States Of America, As Represented By The Secretary Of Agriculture Fusion de peptidoglycane hydrolases à un domaine de transduction des protéines pour éradiquer à la fois les pathogènes gram-positifs extracellulaires et intracellulaires
US20140120074A1 (en) 2011-04-27 2014-05-01 Lysando Ag Antimicrobial agents
CN103703127A (zh) 2011-05-04 2014-04-02 迈克瑞欧斯人体健康有限公司 一种多肽
SG11201407284TA (en) 2012-05-07 2014-12-30 Micreos Human Health Bv Polypeptide mixes with antibacterial activity
US9206411B2 (en) * 2012-06-13 2015-12-08 The United States Of America, As Represented By The Secretary Of Agriculture Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus
SG11201707345VA (en) 2015-03-12 2017-10-30 Micreos Human Health Bv Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
EP3144387B1 (fr) 2015-09-15 2018-03-14 Micreos Human Health B.V. Nouveau polypeptide endolysine
US11427812B2 (en) 2016-11-18 2022-08-30 Lysando Ag Antimicrobial agents against Staphylococcus aureus
CN112368376A (zh) * 2018-03-29 2021-02-12 康特拉费克特公司 溶素-抗微生物肽(amp)多肽构建体、溶素、其分离的编码多核苷酸及其用途
WO2020104216A1 (fr) * 2018-11-19 2020-05-28 Unilever N.V. Composition antimicrobienne pour inhiber sélectivement la croissance de bactéries p. acnes
CA3213821A1 (fr) * 2021-03-19 2022-09-22 Eligo Bioscience Utilisation therapeutique de post-biotiques modifies comprenant des bacteriocines et/ou des endolysines
WO2022195108A2 (fr) * 2021-03-19 2022-09-22 Eligo Bioscience Utilisation cosmétique de postbiotiques modifiés comprenant des bactériocines et/ou des endolysines

Also Published As

Publication number Publication date
FR3149202A1 (fr) 2024-12-06
FR3149202B1 (fr) 2026-04-10
CN121941486A (zh) 2026-04-28
WO2024246305A1 (fr) 2024-12-05

Similar Documents

Publication Publication Date Title
AU2022203101A1 (en) Novel bacterial ferment of Lactobacillus species
JP7551323B2 (ja) 皮膚常在菌バランス改善剤
WO2014115726A1 (fr) Composition antibactérienne
JP2023536047A (ja) ケラチン物質をケアするためのスフィンゴモナス（Ｓｐｈｉｎｇｏｍｏｎａｓ）発酵物抽出物を含む組成物
RU2729982C1 (ru) Противомикробная смесь, содержащая 4-(3-этокси-4-гидроксифенил)бутан-2-он и соединение на основе органической кислоты, и косметическая композиция, содержащая ее
CN117897132A (zh) 用于重新平衡皮肤微生物组的含后生元共混物的个人护理组合物
KR101779131B1 (ko) 피부 외용제용 보존제, 이를 포함하는 화장료 조성물 및 약학 조성물
EP4719329A1 (fr) Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et d'une huile
EP4719330A1 (fr) <smallcaps/>? ? ?staphylococcus aureus? ? ? ? ?composition cosmétique comprenant une endolysine dérivée d'un phage deet un alcool aromatique
WO2024246336A1 (fr) Composition cosmétique comprenant une endolysine et un tensioactif non ionique comprenant un résidu glucidique
EP4719335A1 (fr) Composition cosmétique comprenant une endolysine et une charge organique
JP2023177301A (ja) 皮膚マイクロバイオームに親和性を有する化粧料組成物
WO2024246335A1 (fr) Composition cosmétique comprenant une endolysine et un composé de formule (i)
WO2025045889A1 (fr) Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et un polyhydroxyalcane
WO2025045893A1 (fr) Composition cosmétique comprenant une endolysine et des particules d'aérogel de silice hydrophobe
KR101945987B1 (ko) 티로솔을 포함하는 피부 외용제용 보존제, 이를 포함하는 화장료 조성물 및 약학 조성물
JP7667093B2 (ja) 皮膚常在菌叢のバランス改善剤
EP4719332A1 (fr) Composition cosmétique anhydre comprenant une endolysine dérivée du staphylococcus aureus phage dephage et du mannitol
FR3149209A1 (fr) Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique
FR3149206A1 (fr) Composition cosmétique aqueuse comprenant une endolysine et du tréhalose
FR3152395A1 (fr) Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et la 4-hydroxyacetophenone
FR3149208A1 (fr) Composition cosmétique, notamment aqueuse, comprenant une endolysine et un pullulane
FR3152393A1 (fr) Composition cosmétique comprenant une endolysine dérivée d’un phage de Staphylococcus aureus et une charge minérale
FR3149203A1 (fr) Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane
WO2024241070A1 (fr) Composition cosmétique comprenant une endolysine et un alcool polyvinylique

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251202

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR